Abstract: Background: Acne in women is often associated with anxiety and depression, and may persist from adolescence as well as manifest for the first time in adulthood. Genetic and hormonal factors contribute to its etiopathogenesis, and maintenance treatment is required, usually for years, due to its clinical evolution. oBjective: To develop a guide for the clinical practice of adult female acne. Methods: A team of five experts with extensive experience in acne conducted a literature review of the main scientific evidence and met to discuss the best practices and personal experiences to develop a guide containing recommendations for the clinical practice of adult female acne. results: The group of specialists reached consensus on the main guidelines for clinical practice, providing detailed recommendations on clinical picture, etiopathogenesis, laboratory investigation and treatment of adult female acne. conclusion: Different from teenage acne, adult female acne presents some characteristics and multiple etiopathogenic factors that make its management more complex. This guide provides recommendations for best clinical practices and therapeutic decisions. However, the authors consider that additional studies are needed in order to provide more evidence for adult female acne to be better understood.
INTRODUCTION
Acne affects an increasing number of adult females, impairing quality of life, with significant negative psychological effect and social impact. Adult female acne (AFA) is defined as one that affects women over the age of 25 and may persist continuously or intermittently from adolescence or manifest for the first time in this period.
It is believed that genetic and hormonal factors contribute to the pathogenesis of AFA, characterized by chronic evolution, requiring maintenance treatment, in some cases for years.
tive than that of adolescents, with less tolerance to topical medications. 8, 11 Table 1 demonstrates two clinical forms of AFA, according to the classification of Preneau and Dreno. 8 Recently, the classic AFA location on the lower third of the face was questioned. 9 Studies have observed cases with localization on other areas of the face and back. One study showed that most women (89.8%) had involvement of multiple facial areas, such as the forehead, malar region, mandibular area and temporal region, with a similar severity spectrum to adolescents. The most common clinical presentation was mixed facial acne, with noninflammatory and inflammatory lesions. The majority of the women (93.7%) had comedones, and 48.4% presented lesions on the trunk and only 11.2% on the mandibular regions.
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Severity scales
It is believed that AFA is different from juvenile acne due to its clinical evolution. 12 Scales have been developed to validate a severity score for each type of acne and thus ensure the best treatment.
These include the GEA (Global Evaluation Acne) scale and, more recently, the AFAST (Adult Female Acne Scoring Tool), which includes the submandibular region evaluation, as shown in table 2.
12,13

ETHIOPATHOGENESIS
The etiopathogenesis of acne vulgaris involves a complex interaction between the main factors such as: genetic predisposition;
androgenic hormone stimulation leading to an increase in sebaceous secretion; alteration of the lipid composition; follicular hyperkeratinization; bacterial colonization mainly by Propionibacterium acnes (P. acnes) and periglandular dermal inflammation. 14 Currently, inflammation is considered a key component and can be detected on histopathological and immunohistochemical examination in apparently non-inflammatory acneic lesions such as comedones and even in perilesional areas, without lesions (subclinical) . 15, 16 The causes of AFA have not yet been fully elucidated. Several other factors have been postulated as triggers or aggravating factors, such as: exposure to ultraviolet radiation, stress, obesity, diet, smoking, sleep disorders, cosmetics, medications, excessive skin washing, possible resistance to P. acnes and endocrine deficiency diseases. 1 Currently, the deficiency of the epidermal barrier function has also been reported as a relevant change. The damage of the barrier and the consequent increase in transepidermal water loss may be responsible for the onset of the inflammatory cascade that constitutes the central change in the onset of acne. 17, 18 Figure 1 presents the main etiopathogenical factors in AFA. In relation to AFA and hormones, the following are outstanding:
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1) Increased sensitivity of the sebaceous gland to androgenic hormones: As in acne vulgaris, in AFA there is an increase in the number and sensitivity of the receptors located in sebocytes and keratinocytes to circulating androgenic hormones.
2) Increased peripheral hormonal conversion: sebocytes and keratinocytes present an enzymatic system capable of locally producing testosterone and DHT. Hyperactivity and abnormal activity of enzymes related to the metabolism of androgenic hormones such as 5-alpha reductase, 3-beta-hydroxysteroid dehydrogenase and 17-hydroxysteroid dehydrogenase, with increased pre-hormone peripheral conversion (SDHEA, androstenedione and testosterone) into more potent androgenic hormones (testosterone and DHT).
DHT is 5 to 10 times more potent than its precursor, testosterone, and less likely to be metabolized by aromatase into estrogen. 20 3) Worsening of the disease in the premenstrual period in 60 to 70% of women, as well as in premenopausal, pregnancy and during the use of progestin-only contraceptives. In these periods there is a relative increase of the hormones with greater androgenic activity, in relation to estradiol.
4)
Other hormones, besides androgens and estrogens, regulate the production of sebum: the sebaceous gland is a neuroendocrine organ and the production of sebum can also be stimulated, in periods of stress, by neuropeptides and hormones such as melanocortins and corticotropin-releasing hormone (CRH). 21 CRH increases the expression of 3β-hydroxy-steroid dehydrogenase mRNA, the enzyme responsible for the conversion of dihydroepiandrosterone (DHEA) to testosterone. Also neuropeptides, histamine, retinoids, vitamin D and insulin-like growth factor 1 (IGF-1) have been described as regulators of sebum production.
Changes in sebum
Qualitative changes were verified in the components of sebum in the skin with acne. There is a relative decrease of Linoleic Acid (AL), an Essential Fatty Acid (EFA), protector of the glandular epithelial wall. There is also the peroxidation of squalene by the combined action of P. acnes and ultraviolet radiation. These alterations and the presence of free fatty acids resulting from the hydrolysis of triglycerides, through the action of lipases released by P.
acnes, cause damage the epithelium, increasing infundibular keratinization and dermal inflammation.
14
Follicular hyperkeratinizatin
There is an abnormal proliferation of keratinocytes, stimulated by pro-inflammatory cytokines, such as interleukin-1 alpha (IL-1 alpha). This cytokine is triggered by the activation of Toll-like receptors or TLR 2 and 4, related to innate immunity, which recognize molecular patterns present in P. acnes, as well as sebaceous hyper-secretion and squalene peroxidation. 14 The formation of the micro-comedone is also preceded by a mononuclear infiltrate formed mainly by CD4+ T lymphocytes and CD68+ macrophages, which corroborates to the hypothesis of the participation of the inflammatory process in the early stages of acne. 
Bacterial colonization
The main bacterium involved in the pathogenesis of acne is tuitary-adrenal axis and in increased secretion of stress-related hormones, and may also be an aggravating factor for acne. 21 Goulden et al 3 and Poli et al 35 reported stress as a worsening factor for acne in 71% and 50% of women, respectively.
Tobacco
There is a close relationship between smoking and the occurrence of AFA. 36 Studies show that tobacco is the main factor responsible for the appearance of non-inflammatory acne in this age group, with a significant difference between female smokers and nonsmokers. The comedonal form predominates in smokers and is characterized by the presence of micro and macro-comedones and few inflammatory lesions, which led the authors to describe this clinical form as "smoker's face." The sebaceous gland is sensitive to acetylcholine that is stimulated by nicotine. Acetylcholine leads to cellular modulation and differentiation, inducing hyper-keratinization and influencing sebum production and composition, as well as reducing antioxidant agents and increasing peroxidation of sebum components, such as squalene.
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Endocrine diseases
The association of acne with an endocrinopathy characterized by hyper-androgenism usually presents other clinical signs such as: hirsutism, seborrhoea, alopecia, menstrual disorders, ovulatory dysfunction, infertility, early puberty, metabolic syndrome and virilization. 37 The main endocrinopathies that occur with hyper-androgenism are: Polycystic ovary syndrome POS, late congenital adrenal hyperplasia or disfunction and, more rarely, ovarian, adrenal, pituitary and hypothalamic tumors. Increased IGF-1 also inhibits aromatase and prevents the conversion of testosterone to estrogen. In this hyperinsulinemia, there is still a decrease in the hepatic production of SHBG, favoring the elevation of the free androgens that constitute its active form. 37 In adult women with acne and POS, it is important to evaluate the possibil- are also increased as the plasminogen activator inhibitor (PAI) is.
These changes in lipids and the increase in PAI favor arterial hypertension, coronary disease and thrombosis. 37 In women with acne, obesity and PCOS, metabolic syndrome is very common, character- Although most AFA patients show no signs of clinical or laboratory hyperandrogenism, slightly elevated levels of S-DHEA have been observed. 41 DHT could be useful as a primary marker of peripheral androgen production, but its dosage is not recommended in clinical practice, since it is rapidly metabolized and has high affinity for SHBG. 42 A distal metabolite of DHT, produced in androgen-responsive tissues, is 3-alpha, 17-beta-androstanediol glucuronate. In the final phase of metabolization, the enzyme 3α-hydroxy dehydrogenase converts DHT to 3α-androstenediol which undergoes glucuronidation. This modification decreases its affinity for binding proteins, increases its hydrophilicity and facilitates renal excretion. 43 This metabolite can be used as a marker of hyperandrogenism, especially in women with idiopathic hirsutism, but is not useful in AFA.
Another androgenic metabolite of interest is Androsterone
Glucuronate (ADT-G), which corresponds to 93% of all metabolites.
Currently the use of sensitive and specific laboratory techniques, such as liquid chromatography associated with mass spectrometry, for the dosages of this metabolite, allows evaluation of the total androgenic activity of the organism, with great accuracy, showing correlation with the clinical findings.
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TREATMENT OF ADULT FEMALE ACNE
AFA is a therapeutic challenge because it presents a tendency to relapse, even after cycles of oral antibiotics or isotretinoin. 3 The typical evolution of AFA, with frequent relapses, makes maintenance treatment essential. 45 In choosing the treatment, numerous factors must be taken into account: acne severity, response to previous treatments, psychosocial impact, possibility of pregnancy, slow response to treatment and increased risk of sensitive skin irritation. Individual preferences and costs are also important factors. 2, 7 In the Brazilian population, the diversity of phototypes, with a large contingent of patients prone to post-inflammatory hyperchromia, as well as climatic variation limit therapeutic options, contributing to their complexity. Figure 3 presents an algorithm for treating AFA.
TOPICAL TREATMENT
Topical treatments are the most widely used and effective option for treating moderate AFA and for maintenance treatment.
Tolerability and efficacy may contribute to greater adherence to treatment, good outcomes, and patient satisfaction. 46 Therapeutic regimens employing resources directed against two or more fundamental pathogenic factors are the main strategy in cases of mild to moderate intensity of acne.
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Retinoids Adapalene: The efficacy and tolerability of adapalene 0.3% compared to the vehicle in women aged 18-41 was evaluated in an analysis of data obtained in two studies. There was a significant reduction at the 12 th week (P = 0.045) of the inflammatory lesions (-61%) and non-inflammatory lesions (-51%). The main side effects were dryness and "skin discomfort". 48 The concentration of 0.1%
has also been studied with positive results and good tolerance. 49 Tretinoin: Increased efficacy of AFA treatment was demonstrated when tretinoin at 0.025% concentration was associated with spironolactone. In that same study, another group used 0.1% adapalene in cream associated with spironolactone with similar results. Other authors have shown improvement in inflammatory acne in adolescents and adults when using topical tretinoin at concentrations of 0.04% to 0.1% in micro-capsulated presentations.
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Antibiotics Topical antibiotics have a direct anti-inflammatory action reducing perifollicular lymphocytic infiltrate. Due to the significant increase of P. acnes strains resistant to clindamycin and erythromycin, the use of these substances alone is contra-indicated. 
Benzoyl peroxide
In adult women, benzoyl peroxide can induce irritative contact dermatitis or skin dryness, the extent of which is related to the amount and type of product, concentration, and vehicle. Therefore, concentrations of benzoyl peroxide above 5% are not recommended for use in adult women. 7 It can also cause photosensitivity and bleaching of clothing.
Azelaic acid
Azelaic acid 20%, applied twice a day, was evaluated in a study for the treatment of AFA in 241 women, alone or in combination with various treatments (including adapalene, benzoyl peroxide, cosmeceuticals, isotretinoin and oral hormonal contraceptives).
The study concluded that topical treatment improved the Dermatol-ogy Quality of Life Index (DLQI) and reduced the severity of acne.
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Azelaic Acid 15% gel, applied twice daily, was also effective in reducing post-inflammatory pigmentation. 52 There was a significant reduction in the expression of TLR-2 in the skin of adult females with facial acne who used azelaic acid 15% gel or combined oral contraceptive (drospirenone + ethinylestradiol). The authors suggested a possible anti-inflammatory effect of oral contraceptive and azelaic acid in AFA via modulation of this receptor. 53 According to the AFA review, published in 2013, azelaic acid (20% cream or 15% gel) is recommended as the first line of treatment in monotherapy for non-inflammatory and inflammatory acne. Azelaic acid shows similar efficacy to other topical therapies in the treatment of mild to moderate acne and is associated with a favorable tolerability profile and high rates of satisfaction. 7 Finally, it is unlikely that systemic side effects occur with azelaic acid, making it safe for use during pregnancy and breastfeeding. 7 Azelaic acid represents an important option for women of childbearing age and with a desire to become pregnant as it is considered safe by the Food and Drug Administration (FDA).
Dapsone
Dapsone 5% gel was used as treatment twice daily in black adult females with good efficacy and tolerance. In patients with acne vulgaris, it has been shown to be useful when combined with doxycycline and then alone as maintenance for long periods, with the advantage of having no risk for bacterial resistance. 
Retinoids + Antibiotics
The tretinoin-clindamicyn combination has been studied for the treatment of acne; a later analysis included only data from adult females. The combination proved to be more effective in reducing inflammatory and non-inflammatory lesions than the isolated tretinoin or clindamycin or the carrier substance.
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Antibiotics + Benzoyl peroxide
The combination of benzoyl peroxide 3.75% + clindamycin The combined use of spironolactone with topical retinoid seems to provide a superior response to the retinoid treatment isolated in AFA. 61 Spironolactone can be used to promote androgen blockade in patients using levonorgestrel intrauterine devices or to increase androgen blockade in those who opt for combined oral contraceptive pills (OCPs). 62 In these cases, doses of 100 mg daily are safe and rarely associated with side effects. 63 A systematic review published in 2017 concluded that the evidence for its use in the treatment of AFA is still poor, its recommendation is still based on expert opinion or consensus, and randomized, controlled, double-blind trials for the proof of effectiveness are still lacking. [75] [76] [77] [78] Teratogenicity is the most serious and irreversible adverse effect. Fetal exposure to isotretinoin, regardless of dose, at any time during gestation, but especially in the first trimester, can cause serious defects, with an incidence of approximately 28%. 79 The occurrence of depression, suicidal ideation or attempted suicide associated with isotretinoin in the treatment of acne vulgaris has been reported in the literature of case reports and case-control studies. The observed incidence ranges from less than 1% to 3%, while in the general population it is estimated to be between 1.6 and 7.5%, with an average of 3%. 80 Numerous studies have concluded that the drug more often determines improvement or cure of depressive symptoms that have been proven to be related to acne and cause depression. 81, 82 Population studies have not confirmed this association.
However, the recommendation remains to monitor symptoms and, if necessary, request psychiatric evaluation and treatment. It is worth remembering that in adult females, emotional and psychic disorders, stress, insomnia, and other symptoms are common. 21 The development of Inflammatory Bowel Disease (IBD), particularly ulcerative colitis was related to isotretinoin. However, several population-based, case-control studies have concluded that this association does not exist. 83, 84 On the other hand, Crohn's disease has been reported with the use of tetracycline-class antibiotics, particularly doxycycline and even topical treatments for acne, evidencing that the causal factor is the disease and not the therapeutic option. 85 There seems to be a misconception about the true triggering factor. A recent meta-analysis has shown that there is no increased risk of developing IBD after exposure to isotretinoin. cents, it is currently recommended to repeat the tests 4 to 6 weeks after starting treatment and reassessments only for those who have changed. [86] [87] [88] The recommended daily dose is 0.5 to 1.0mg / kg, after meals (preferably fatty), for a period of 6 to 12 months, up to a total dose of 120 to 150mg/kg. 66, 67 There are reports of use of lower daily doses, without the need to reach the total dose of 120mg/kg body weight. The benefits of regimens with 0.3 to 0.4mg/kg/day, 20mg/day, 20mg every other day, 5mg/day, in the treatment of moderate acne, with the same efficacy, fewer side effects and greater adherence to treatment. [89] [90] [91] However, this is not recommended for use in leaflets. These regimens may be a useful option for AFA resistant to topical and hormonal treatments by reducing adverse events. However, effective prevention of pregnancy is necessary since these women may be of childbearing age and the risk of teratogenicity is equal to the use at usual doses. 79 To begin treatment in women of childbearing age, it is necessary to inform of the risks, the need for two contraceptive methods, pregnancy tests and to wait for menstruation. In adult females, particularly those with overweight tendency or obese, or with hormonal changes, more frequent laboratory monitoring becomes essential. There has been an increased risk of elevated cholesterol and triglycerides and weight gain. 92, 93 No changes were detected in serum androgens and insulin. 93 Adult women with hyperandrogenism often require more than one course of treatment with isotretinoin, in addition to hormones. One measure that may contribute to avoid recurrence is maintenance therapy with adapalene, benzoyl peroxide, or azelaic acid for 6 months to 2 years. 94 A risk of relapse that is 3.5 times greater has been reported in women who did not use concomitant anti-androgen therapy.
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Adjuvant treatments
Cosmeceuticals and cosmetics
The topical and systemic treatment for acne can cause dryness, irritation, damage to the epidermal barrier, increased transepidermal water loss and inflammation, and may reduce adhesion.
Moisturizers may contribute to reduce these adverse events of topical products and oral isotretinoin by avoiding the impairment of the epidermal barrier that is essential to prevent or reduce inflammation. 7, 96, 97 Many authors consider that because cosmeceuticals are available without prescription and medical supervision, there may be harm in educating patients about their dermatoses (such as acne).
Intensive advertising is highly targeted at adult females and may induce them to self-medication with ineffective and skin-irritating products, as well as causing delay in seeking suitable dermatological care, increasing the risk of continuation. In addition, data on acne efficacy is limited and information presented by companies is much more based on in vitro research than in randomized controlled trials of finished products. and accompanied by increased seborrhea. They are not superior to medicines for these forms and there is no data for severe acne. 99 Niacinamide may be useful for antimicrobial, sebostatic, anti-inflammatory effects, inhibition of melanosome transfer, increased synthesis of ceramides, inhibition of nitric oxide and consequent changes in capillary permeability. 100 As some anti-acne agents may cause skin dryness, erythema and discomfort, moisturizers and cleansing agents (preferably soapfree and near-skin pH) are recommended as an essential part of the therapeutic regimen in AFA. 7 It is necessary to add photo-protection with non-comedogenic products capable of also providing comfort and hydration. In certain climatic conditions the use of moisturizer may be crucial for adherence to treatment, counteracting dryness and improving the barrier function of the stratum corneum. other procedures at different times, particularly when they are deep. 106, 110, 111 In this situation, the peel acts as a preparation of the skin, making its surface more homogeneous. At the moment there is no laser technology whose target is the sebaceous gland and that can destroy it, leading to healing. Two suggestions have been discussed. One associates an integrated cooling and vacuum system applied to the skin followed by the application of 3 to 4 pulses of the 1540-nm medium-erbium: glass infrared
laser. An open, uncontrolled study including 12 patients with mild to moderate acne used this method in 4 to 6 sessions, with a 2-week interval. The improvement scores were 3.6 and 2.0, on a scale of 0 to 4, after one and 3 months of the last session, without adverse events. 115 Another recently developed method is the use of a suspension of inert gold micro-particles with silica center applied with 8-minute massage on the face followed by 800nm laser application.
There are 3 sessions, with intervals of 2 weeks. There are reports of improvement of up to 61% of inflammatory lesions. Studies related to acne point to a negative influence on quality of life, including the presence of signs and symptoms of depression and anxiety, such as anger and low self-esteem. [125] [126] [127] The use of disease-specific questionnaires, such as Quality of Life in Acne (Acne-QoL), already translated and validated for Brazilian Portuguese, quantifies the impact of acne on quality of life. [128] [129] [130] The literature shows that the impact on quality of life does not always correlate with the severity of acne. In some cases, females with mild clinical conditions have a high impact on quality of life. 126 Studies have also shown that the psychological impact of acne appears to affect more females than males. 131 In any case, the physician's attention, good relationship with the patient and adequate treatment, topical and/or systemic, although not completely effective demonstrates a positive impact on quality of life. For all these issues, AFA is a challenge in clinical practices and should be further understood.q
